Barriers and facilitators to HIV pre-exposure prophylaxis uptake, adherence, and persistence among transgender populations in the United States: a systematic review

M Dang, AI Scheim, M Teti, KG Quinn… - AIDS patient care and …, 2022 - liebertpub.com
HIV pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV; however, PrEP
use among transgender individuals remains low. We conducted a systematic review to …

[HTML][HTML] Toward greater pre-exposure prophylaxis equity: increasing provision and uptake for Black and Hispanic/Latino individuals in the US

RA Bonacci, DK Smith, BO Ojikutu - American journal of preventive …, 2021 - Elsevier
Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV acquisition and is a
critical tool in the Ending the HIV Epidemic in the US initiative. However, major racial and …

Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication

SB Bass, PJ Kelly, J Brajuha, L Gutierrez-Mock… - BMC public health, 2022 - Springer
Background Trans women are at increased risk for HIV infection yet are less likely to use pre-
exposure prophylaxis (PrEP) medication as a preventive measure. PrEP messaging and …

Barriers to Pre-Exposure Prophylaxis (PrEP) use for HIV: an integrative review

M Antonini, IE Silva, HC Elias, L Gerin… - Revista Brasileira de …, 2023 - SciELO Brasil
Objectives: to identify and synthesize scientific evidence on the barriers and difficulties for
Pre-exposure Prophylaxis (PrEP) use and compliance for HIV. Methods: an integrative …

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: results from a …

JD Tapsoba, J Cover, C Obong'o, M Brady… - Plos …, 2022 - journals.plos.org
Background In sub-Saharan Africa (SSA), adolescent girls and young women (AGYW) ages
15 to 24 years represent< 10% of the population yet account for 1 in 5 new HIV infections …

Control groups for HIV prevention efficacy trials: what does the future hold?

H Janes, S Buchbinder - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
Efficacy trials of new HIV prevention interventions are feasible but require careful
consideration, given the complexity and dynamic state of the prevention field. While …

Exploring the association between gender affirmation and PrEP use among transgender women in New York City

AV Rivera, JM Lopez, SL Braunstein - AIDS and Behavior, 2023 - Springer
Abstract Black and Hispanic/Latina transgender women are inequitably impacted by HIV; yet
gaps in PrEP use exist. Among a sample of mostly Black and Hispanic/Latina transgender …

The impact of COVID-19 on the HIV continuum of care: challenges, innovations, and opportunities

JYH Kim, SK Barth, AK Monroe, S Ahsan… - Expert review of anti …, 2023 - Taylor & Francis
ABSTRACT Introduction In February 2019, the United States (US) launched the Ending the
HIV Epidemic (EHE) initiative with emphasis on improving the various steps of the Human …

Facilitators of PrEP persistence among Black and Latinx transgender women in a PrEP Demonstration Project in Southern California

ED Storholm, A Ogunbajo, CL Nacht, C Opalo… - Behavioral …, 2024 - Taylor & Francis
Black and Latinx transgender women in the United States (US) are at disproportionately
high risk for HIV. Although HIV pre-exposure prophylaxis (PrEP) reduces the risk of HIV …

A scoping review investigating relationships between depression, anxiety, and the PrEP care continuum in the United States

SJ Miller, SE Harrison, K Sanasi-Bhola - International journal of …, 2021 - mdpi.com
Men who have sex with men and transgender women in the United States are at increased
risk for HIV and may benefit from pre-exposure prophylaxis (PrEP), a once-a-day pill to …